Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Nuchal translucency of 3.0‐3.4 mm an indication for NIPT or microarray? Cohort analysis and literature review

19 Apr 2020

Abstract excerpt

INTRODUCTION: Currently fetal nuchal translucency (NT) ≥3.5 mm is an indication for invasive testing often followed by chromosomal microarray. The aim of this study was to assess the risks for chromosomal aberrations in fetuses with an NT 3.0-3.4 mm, to determine whether invasive prenatal testing would be relevant in these cases and to assess the residual risks in fetuses with normal non-invasive prenatal test...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gestational Trophoblastic Disease Studies
Share to Parvovirus B19 Infection Studies
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32306377
DOI: 10.1111/aogs.13877

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Nuchal translucency of 3.0‐3.4 mm an indication for NIPT or microarray? Cohort analysis and literature reviewPMID 32306377Read ↗

Outcomes associated with fetal nuchal translucency between 3.0 and 3.4 mm in the first trimesterSemantic proximity Read ↗

Increased nuchal translucency thickness and normal chromosomal microarray: Danish nationwide cohort studySemantic proximity Read ↗

Risk of Clinically Significant Chromosomal Microarray Analysis Findings in Fetuses With Nuchal Translucency From 3.0 mm Through 3.4 mmSemantic proximity Read ↗

Cut‐off value of nuchal translucency as indication for chromosomal microarray analysisSemantic proximity Read ↗

Associations between genomic aberrations, increased nuchal translucency, and pregnancy outcomes: a comprehensive analysis of 2,272 singleton pregnancies in women under 35Semantic proximity Read ↗

Ultrasonographic Fetal Nuchal Translucency Measurements and Cytogenetic OutcomesSemantic proximity Read ↗

Reexamining the optimal nuchal translucency cutoff for diagnostic testing in the cell-free DNA and microarray era: results from the Victorian Perinatal Record Linkage study.Semantic proximity Read ↗

Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotypeSemantic proximity Read ↗

Application of chromosomal microarray in fetuses with increased nuchal translucencySemantic proximity Read ↗

Elevated nuchal translucency, is it time to discuss the cut off?. A retrospective studySemantic proximity Read ↗

Abnormal Nuchal Translucency and Outcomes of Singleton Pregnancies (Antop) Study: An 8 -year Retrospective Cohort AnalysisSemantic proximity Read ↗

Combined Application of Chromosome Karyotype and Microarray Analysis in Fetus With Increased Nuchal TranslucencySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.